09:15 AM - 09:30 AM

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study.

Location: Le Meridian AL Khobar, Saudi Arabia

Social Share

× How can I help you?